CIK 0001618835 · Non-accelerated filer<br>Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208527075
- Phone
- (858) 550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-05-12 | Rutherford Colin Director | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2020-05-12 | O'Brien Anthony Stephen Director | Grant or award · Common Stock | +50,000 | 50,000 | ||
| 2020-05-12 | Greer Gillian Director | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2020-05-12 | Rarick Lisa Dale Director | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2020-05-12 | Kamdar Kim P. Director | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2020-05-12 | Hall William Walmsley Director | Grant or award · Stock option (right to buy) | +50,000 | 50,000 | ||
| 2020-05-06 | Barrans Russell Chief Commercial Officer | Shares withheld for taxes | −3,802 | $5.24 | $20K | 328,438 |
| 2020-05-06 | Culwell Kelly Chief Medical Officer | Shares withheld for taxes | −7,792 | $5.24 | $41K | 186,434 |
| 2020-05-06 | File Justin J. Chief Financial Officer | Shares withheld for taxes | −8,420 | $5.24 | $44K | 322,677 |
| 2020-05-06 | PELLETIER SAUNDRA L Chief Executive Officer | Shares withheld for taxes | −16,905 | $5.24 | $89K | 649,230 |
| 2020-05-06 | Fitzpatrick Alexander A General Counsel and Secretary | Shares withheld for taxes | −7,802 | $5.24 | $41K | 205,529 |
| 2020-05-01 | Culwell Kelly Chief Medical Officer | Sale | −1,000 | $4.75 | $5K | 194,226 |
| 2020-04-30 | Culwell Kelly Chief Medical Officer | Sale | −1,000 | $4.66 | $5K | 195,226 |
| 2020-04-01 | Lynch Thomas G Director | Grant or award · Restricted Stock Units | +150,000 | 150,000 | ||
| 2020-03-31 | Lynch Thomas G Director | Option exercise | +37,500 | 325,000 | ||
| 2020-03-31 | Lynch Thomas G Director | Option exercise · Restricted Stock Units | +37,500 | 0 | ||
| 2020-02-25 | Rarick Lisa Dale Director | Grant or award · Stock option (right to buy) | +75,000 | 75,000 | ||
| 2020-02-19 | Culwell Kelly Chief Medical Officer | Sale | −1,000 | $7.00 | $7K | 196,226 |
| 2020-02-19 | Barrans Russell Chief Commercial Officer | Sale | −14,957 | $6.50 | $97K | 332,240 |
| 2020-02-05 | Barrans Russell Chief Commercial Officer | Grant or award | +899 | $5.21 | $5K | 197,197 |
Page 5 of 20 · 383 trades